MIRATI THERAPEUTICS, INC. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/84e309a3-92cc-4c52-a0d2-b11fdb8a145a/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $12.4M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-005576 |
| FY 2021 | $72.1M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-004246 |
| FY 2020 | $13.4M | 2020-01-01 – 2020-12-31 | evidence 0001628280-21-003315 |
| FY 2019 | $3.3M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002301 |
| FY 2018 | $12.9M | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-002289 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001628280-19-002289 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001628280-19-002289 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MIRATI THERAPEUTICS, INC. — all facts · Net Income · Operating Income